IRONWOOD PHARMACEUTICALS INC - NOTE 0.750% 6/1

Historical Portfolio Holders from Q3 2020 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Debt / NOTE 0.750% 6/1
Principal, excl. options Q1 2024
189 M
Holdings value Q1 2024
$188 M
Value change Q1 2024
-$15.4 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
15
Number of buys Q1 2024
10
Number of sells Q1 2024
-11
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
-0.001%
CUSIP
46333XAF5
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q1 $189 M $188 M -$15.4 M $0.99 15
2023 Q4 $202 M $214 M -$61.5 K $1.05 18
2023 Q3 $206 M $204 M +$12 M $0.99 23
2023 Q2 $201 M $203 M +$1.59 M $1.00 23
2023 Q1 $200 M $201 M +$25.5 M $1.00 20
2022 Q4 $174 M $188 M -$6.54 M $1.07 23
2022 Q3 $188 M $185 M -$11.9 M $1.00 22
2022 Q2 $199 M $206 M -$6.88 M $1.05 18
2022 Q1 $215 M $243 M +$21.4 M $1.14 19
2021 Q4 $191 M $213 M -$588 K $1.11 15
2021 Q3 $199 M $235 M -$185 K $1.18 18
2021 Q2 $199 M $234 M +$2.18 M $1.18 18
2021 Q1 $199 M $221 M -$39.2 K $1.11 17
2020 Q4 $199 M $212 M +$2.77 M $1.12 18
2020 Q3 $187 M $185 M +$185 M $0.99 15